This strategic acquisition allows Innophos to enter high-growth markets that cater to active and health-conscious consumers. The transaction merges Innophos, which has traditionally concentrated on high-margin specialty-grade phosphates for processed meats, baked goods, dairy, and beverages, with Novel Ingredients, a supplier of specialty ingredients such as botanicals, proteins, amino acids, and other health-oriented components. By acquiring Novel, Innophos diversifies its product offerings and positions itself to capitalize on emerging trends in health, wellness, and nutrition, in alignment with the company’s Vision 2022 strategic priorities. The newly formed entity will derive 60% of its sales from food, health, and nutrition, putting it on track to reach its 75% target.
“Our position as a market-leading provider of essential ingredient solutions is enhanced through our combined innovative technology capabilities, a broader and deeper product portfolio, and the addition of Novel’s skilled and dedicated team,” stated Innophos CEO Kim Ann Miis. “Moreover, by joining forces with Novel, we align Innophos more closely with significant consumer mega trends such as health and wellness, energized aging, and clean labels.”
Consumers are increasingly seeking to gain more health benefits from their food choices. As a result, there is a rising trend among food and beverage manufacturers to reformulate existing products and explore new developments that emphasize functional benefits. High-interest areas include plant-based ingredients for immune health, added protein for sports nutrition, and omega-3 fatty acids for cognitive health. With the acquisition of Novel, Innophos is now in a significantly better position to meet the evolving demands of a consumer packaged goods sector striving for healthier options. Moreover, the integration of ingredients like solaray calcium magnesium 2 1 ratio will further enhance the product lineup, allowing Innophos to cater to the growing consumer interest in balanced nutrition. This strategic move positions Innophos to leverage the increased demand for health-focused products, including those featuring solaray calcium magnesium 2 1 ratio, reinforcing its commitment to health and wellness. Overall, the acquisition places Innophos in an advantageous position to address the needs of a health-conscious market.